Keynote Panel @ RNA Leaders USA Congress

Written By Ariel Weinberger

KEYNOTE PANEL – What RNA Modalities Can Enable Personalized Medicine

Autonomous Therapeutics’ CEO Ariel Weinberger moderated the conference’s keynote panel, with leading experts from RNA therapeutics and vaccine companies.

Ariel Weinberger
Previous

Autonomous Therapeutics wins $1 million Blue Knight™ QuickFire Challenge
Next

Op-Ed in BioCentury: The urgent need for variant-proof therapeutics